Rat Behavioral Data on Ketamine and Dexmedetomidine for Methamphetamine Agitation

A 534.8 KB PDF file published on figshare by Madhuri Budamkayala in April 2026. The data provides proof-of-concept support for using dexmedetomidine and ketamine to treat methamphetamine-induced agitation in rats, comparing locomotor activity, sedation depth, and side effects across different drug combinations.

Use Cases

• Modeling drug efficacy for agitation attenuation based on locomotor activity measurements.
• Analyzing sedation depth and arousability based on the rat coma scale scores.
• Comparing side effect profiles of different drug combinations mentioned in the study.
• Training models to predict behavioral outcomes from preclinical pharmacological interventions.

Strengths

• Data includes specific, controlled dosages (e.g., 1 mg/kg METH, 0.032 mg/kg DEX, 56 mg/kg KET).
• Measurements cover a defined 90-minute observation period after administration.
• Published under a permissive CC-BY-4.0 license for reuse.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is derived from a single animal model (male rats), which may limit generalizability.

Provenance

Source

figshare

Collection Method

Experimental study measuring locomotor activity, rat coma scale, and side effects in a controlled laboratory setting.

Time Range

Observation period of 90 minutes post-drug administration as described.

Freshness

Last updated 2026-04-15 05:01:12; freshness should be verified.

Geography

Laboratory study, geographic location not specified.